Results 101 to 110 of about 1,942 (154)

Using an In Vitro-In Vivo Correlation for the ‘Bioequivalence by Design’ Development of an Immediate Release Carbamazepine Product [PDF]

open access: yes, 2018
The quality of a drug product may be characterized by the consistency with which its indicated clinical effect, and safety profile, is experienced by the patient.
Steinbach, Douglas
core   +1 more source

Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. Case example: Naproxen

open access: yes, 2019
Background: Physiologically-based population pharmacokinetic modeling (popPBPK) coupled with in vitro biopharmaceutics tools such as biorelevant dissolution testing can serve as a powerful tool to establish virtual bioequivalence and set clinically relevant specifications.
Loisios-Konstantinidis, Ioannis   +4 more
openaire   +1 more source

In silico prediction of bioequivalence of atorvastatin tablets based on GastroPlus™ software. [PDF]

open access: yesBMC Pharmacol Toxicol, 2023
Wang L   +6 more
europepmc   +1 more source

Computer Simulations as a Tool for Optimizing Bioequivalence Trials [PDF]

open access: yes, 2012
Alfredo García-Arieta   +6 more
core   +1 more source

Mechanistic Modelling of Lidocaine and Prilocaine Absorption from EMLA Cream upon Topical Application using Physiologically Based Pharmacokinetic Modelling. [PDF]

open access: yesAAPS PharmSciTech
Telaprolu KC   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy